ClinConnect ClinConnect Logo
Search / Trial NCT07047599

Uroflowmetry and IPSS Factors Influencing Surgical Decision

Launched by MARMARA UNIVERSITY · Jun 30, 2025

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

Lower Urinary Tract Symptoms Benign Prostate Obstruction (Bpo) Voiding Dysfunction Ipss Urolfowmetry

ClinConnect Summary

This clinical trial is studying men who have trouble with their urinary flow, often caused by an enlarged prostate or other issues affecting how they urinate. The researchers want to find out which symptoms or test results make men more likely to consider having surgery to improve their urinary problems. To do this, they will ask men about their symptoms, how these affect their quality of life, and measure urine flow using a simple test called uroflowmetry. The goal is to better understand which factors are most important when deciding if surgery might be the right choice.

Men aged 40 and older who are experiencing urinary symptoms and visiting a clinic for evaluation may be eligible to take part, as long as they can complete a symptom questionnaire and uroflowmetry test. Participants will be asked if they might consider surgery in the future if their symptoms don’t improve. This study is observational, meaning it only collects information and does not involve any treatment or changes to care. It’s important to note that men with prior prostate surgeries, urinary infections, certain neurological conditions, or known cancers will not be eligible to join. Participants can expect a straightforward process involving questionnaires and non-invasive urine flow tests during their regular clinic visits.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Male patients aged 40 years and older
  • Presenting with lower urinary tract symptoms (LUTS)
  • Able to complete the IPSS questionnaire
  • Undergoing uroflowmetry as part of routine evaluation
  • Able and willing to provide informed consent
  • Exclusion Criteria:
  • History of urological surgery (e.g., TURP, HoLEP, radical prostatectomy)
  • Presence of known prostate or bladder cancer
  • Active urinary tract infection at the time of evaluation
  • Neurological conditions affecting voiding (e.g., Parkinson's disease, spinal cord injury)
  • Inability to perform uroflowmetry or incomplete IPSS data

About Marmara University

Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported